An Individualized Approach to Type 2 Inflammation–Driven COPD Care
February 24 @ 7:00 pm - 8:00 pm EST
Event Navigation

Key Reasons to Attend
- Learn about the role that type 2 inflammation plays in COPD and which patients might benefit from biologic therapies
- Get up to speed on the latest clinical evidence on T2i-targeted biologic agents in the treatment of COPD
- Hear strategies for creating personalized care plans for your patients, incorporating an interprofessional care team
About ECHO®
![]() |
Project ECHO®, developed in 2003 by the University of New Mexico, is a virtual knowledge-sharing model that connects expert multidisciplinary teams with community-based clinicians, often from rural or underserved areas, through regular videoconferencing. Sessions include didactic presentations and learner presented deidentified case-based discussions, fostering peer-to-peer learning and mentorship. This “all teach, all learn” approach promotes continuous learning and collaboration, empowering clinicians to implement best practices and improve healthcare delivery in their communities, with long-lasting impacts that extend beyond traditional training methods. |
A key component of the COPD ECHO® sessions is the case presentation from learners. We invite you to submit a case for an upcoming discussion during which our expert multidisciplinary faculty and your peers will provide practice feedback you will be able to use to improve care for your patients with COPD.
*This link will direct you to a HIPAA-compliant website administered by the Boston University Chobanian & Avedisian School of Medicine.
